| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225439.2 |
Ponatinib |
Breast invasive carcinoma |
0.030130551 |
Sensitive |
| ENSG00000225439.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022328328 |
Sensitive |
| ENSG00000225439.2 |
Ponatinib |
Esophageal cancer |
0.019771938 |
Resistant |
| ENSG00000225439.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043788776 |
Resistant |
